Healthcare provider profile · identity verified

Sherrell L Roberts, MD

Allopathic & Osteopathic Physicians|General Practice · MONTICELLO, KY · NPI 1780675801

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Sherrell L Roberts, MD received $88.23 in general payments during 2025 across 5 reported records.

Vanda Pharmaceuticals Inc. accounted for 82.4% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic, Rybelsus.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 347 claims for Ozempic by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 74 claims for Rybelsus by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Wegovy as an associated drug or biological on 183056 records involving 75256 distinct recipient NPIs. Public Medicare Part D data also shows 20 claims for Wegovy by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$88.23

5 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Vanda Pharmaceuticals Inc.	Unresolved — no canonical attribution shown	$72.70	82.4%	4	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$15.53	17.6%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$88.23	5

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
FANAPT Normalized: fanapt	Drug	Vanda Pharmaceuticals Inc.	$72.70	4	2025
Source payment records 2025-06-13 · Vanda Pharmaceuticals Inc. · $19.93 · Open Payments source 2025-08-26 · Vanda Pharmaceuticals Inc. · $18.23 · Open Payments source 2025-09-09 · Vanda Pharmaceuticals Inc. · $14.13 · Open Payments source 2025-10-17 · Vanda Pharmaceuticals Inc. · $20.41 · Open Payments source
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$15.53	1	2025
Source payment records 2025-03-12 · Novo Nordisk Inc · $15.53 · Open Payments source
Rybelsus Normalized: rybelsus	Drug	Novo Nordisk Inc	$15.53	1	2025
Source payment records 2025-03-12 · Novo Nordisk Inc · $15.53 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
Ozempic ozempic	2025	Ozempic	2024	347	exact normalized	Medicare Part D
Rybelsus rybelsus	2025	Rybelsus	2024	74	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	347	60
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Rybelsus open payments reported associated product	CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076	Rybelsus · 2024 Exact normalized brand match · 1 Part D row	74	17
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Wegovy open payments reported associated product	CMS Open Payments — General Payments 183056 supporting records · 75256 recipient NPIs · example record 1188130070	Wegovy · 2024 Exact normalized brand match · 1 Part D row	20	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1187	181
Omeprazole	Omeprazole	948	224
Montelukast Sodium	Montelukast Sodium	843	208
Levothyroxine Sodium	Levothyroxine Sodium	836	166
Amlodipine Besylate	Amlodipine Besylate	802	209
Furosemide	Furosemide	755	184
Potassium Chloride	Potassium Chloride	747	189
Pantoprazole Sodium	Pantoprazole Sodium	699	162
Gabapentin	Gabapentin	685	116
Atorvastatin Calcium	Atorvastatin Calcium	653	183
Sertraline Hcl	Sertraline Hcl	527	107
Prednisone	Prednisone	505	225
Lisinopril	Lisinopril	490	130
Glimepiride	Glimepiride	453	108
Amoxicillin	Amoxicillin	444	199
Metoprolol Succinate	Metoprolol Succinate	395	108
Meloxicam	Meloxicam	384	133
Trazodone Hcl	Trazodone Hcl	382	88
Metformin Hcl	Metformin Hcl	371	94
Tamsulosin Hcl	Tamsulosin Hcl	361	91
Doxycycline Monohydrate	Doxycycline Monohydrate	349	191
Albuterol Sulfate Hfa	Albuterol Sulfate	348	86
Ozempic	Semaglutide	347	60
Pravastatin Sodium	Pravastatin Sodium	339	86
Losartan Potassium	Losartan Potassium	294	62
Tizanidine Hcl	Tizanidine Hcl	289	66
Azithromycin	Azithromycin	288	192
Clopidogrel	Clopidogrel Bisulfate	281	79
Alprazolam	Alprazolam	278	52
Tramadol Hcl	Tramadol Hcl	277	58
Nortriptyline Hcl	Nortriptyline Hcl	267	57
Rosuvastatin Calcium	Rosuvastatin Calcium	266	72
Eliquis	Apixaban	264	39
Hydroxyzine Hcl	Hydroxyzine Hcl	261	71
Metoprolol Tartrate	Metoprolol Tartrate	254	71
Atenolol	Atenolol	249	55
Triamcinolone Acetonide	Triamcinolone Acetonide	246	125
Fluticasone Propionate	Fluticasone Propionate	245	64
Cefdinir	Cefdinir	224	148
Promethazine Hcl	Promethazine Hcl	215	77
Ciprofloxacin Hcl	Ciprofloxacin Hcl	214	135
Citalopram Hbr	Citalopram Hydrobromide	210	39
Mirtazapine	Mirtazapine	207	43
Naproxen	Naproxen	204	78
Famotidine	Famotidine	196	50
Celecoxib	Celecoxib	190	56
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	184	64
Linzess	Linaclotide	182	39
Carvedilol	Carvedilol	178	47
Isosorbide Mononitrate Er	Isosorbide Mononitrate	171	38
Metformin Hcl Er	Metformin Hcl	171	44
Warfarin Sodium	Warfarin Sodium	169	21
Mounjaro	Tirzepatide	163	25
Zolpidem Tartrate	Zolpidem Tartrate	160	32
Oxybutynin Chloride Er	Oxybutynin Chloride	159	36
Acetaminophen-Codeine	Acetaminophen With Codeine	158	32
Methocarbamol	Methocarbamol	155	45
Ropinirole Hcl	Ropinirole Hcl	154	31
Memantine Hcl	Memantine Hcl	152	35
Allopurinol	Allopurinol	151	37
Hydrochlorothiazide	Hydrochlorothiazide	150	36
Ondansetron Hcl	Ondansetron Hcl	143	71
Buspirone Hcl	Buspirone Hcl	142	40
Ibuprofen	Ibuprofen	142	47
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	140	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	139	24
Loperamide	Loperamide Hcl	133	47
Venlafaxine Hcl Er	Venlafaxine Hcl	132	20
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	125	31
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	123	25
Simvastatin	Simvastatin	121	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	119	32
Esomeprazole Magnesium	Esomeprazole Magnesium	118	29
Ventolin Hfa	Albuterol Sulfate	116	28
Combivent Respimat	Ipratropium/Albuterol Sulfate	113	19
Ondansetron Odt	Ondansetron	113	56
Spironolactone	Spironolactone	112	25
Fluconazole	Fluconazole	111	54
Clonazepam	Clonazepam	109	16
Olmesartan Medoxomil	Olmesartan Medoxomil	109	26
Diazepam	Diazepam	104	suppressed
Levofloxacin	Levofloxacin	104	79
Duloxetine Hcl	Duloxetine Hcl	103	22
Bupropion Xl	Bupropion Hcl	101	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	101	18
Torsemide	Torsemide	101	21
Escitalopram Oxalate	Escitalopram Oxalate	100	26
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	98	67
Donepezil Hcl	Donepezil Hcl	98	25
Valsartan	Valsartan	97	25
Jardiance	Empagliflozin	95	23
Trulicity	Dulaglutide	94	14
Lorazepam	Lorazepam	91	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	91	18
Amitriptyline Hcl	Amitriptyline Hcl	89	24
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	88	61
Alendronate Sodium	Alendronate Sodium	85	19
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	84	26
Pregabalin	Pregabalin	84	13
Nitroglycerin	Nitroglycerin	83	46
Meclizine Hcl	Meclizine Hcl	82	43
Clonidine Hcl	Clonidine Hcl	80	22
Paroxetine Hcl	Paroxetine Hcl	80	20
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	78	36
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	24
Rybelsus	Semaglutide	74	17
Quetiapine Fumarate	Quetiapine Fumarate	73	16
Synthroid	Levothyroxine Sodium	73	15
Silver Sulfadiazine	Silver Sulfadiazine	72	46
Fluoxetine Hcl	Fluoxetine Hcl	71	16
Glipizide Er	Glipizide	71	16
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	71	16
Januvia	Sitagliptin Phosphate	70	19
Nifedipine Er	Nifedipine	70	21
Diclofenac Sodium	Diclofenac Sodium	67	31
Topiramate	Topiramate	65	17
Cephalexin	Cephalexin	64	42
Glipizide	Glipizide	64	22
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	63	19
Lansoprazole	Lansoprazole	63	18
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	61	suppressed
Benazepril Hcl	Benazepril Hcl	60	13
Glipizide-Metformin	Glipizide/Metformin Hcl	59	12
Doxepin Hcl	Doxepin Hcl	58	13
Doxycycline Hyclate	Doxycycline Hyclate	58	41
Dexlansoprazole Dr	Dexlansoprazole	57	14
Nystatin	Nystatin	57	26
Entresto	Sacubitril/Valsartan	56	17
Labetalol Hcl	Labetalol Hcl	54	suppressed
Ezetimibe	Ezetimibe	53	14
Propranolol Hcl	Propranolol Hcl	53	14
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	51	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	51	15
Cyproheptadine Hcl	Cyproheptadine Hcl	49	16
Doxazosin Mesylate	Doxazosin Mesylate	47	12
Alfuzosin Hcl Er	Alfuzosin Hcl	46	13
Lactulose	Lactulose	46	29
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	46	suppressed
Xarelto	Rivaroxaban	46	14
Enulose	Lactulose	45	22
Finasteride	Finasteride	45	12
Testosterone Cypionate	Testosterone Cypionate	45	16
Prochlorperazine Maleate	Prochlorperazine Maleate	43	13
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	40	12
Metolazone	Metolazone	38	22
Midodrine Hcl	Midodrine Hcl	38	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	36	suppressed
Constulose	Lactulose	35	18
Fenofibrate	Fenofibrate	35	suppressed
Levetiracetam	Levetiracetam	35	12
Ssd	Silver Sulfadiazine	35	28
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	34	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	34	suppressed
Farxiga	Dapagliflozin Propanediol	34	suppressed
Aripiprazole	Aripiprazole	33	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	32	suppressed
Mupirocin	Mupirocin	32	27
Oseltamivir Phosphate	Oseltamivir Phosphate	32	32
Breo Ellipta	Fluticasone/Vilanterol	31	11
Metoclopramide Hcl	Metoclopramide Hcl	31	suppressed
Etodolac	Etodolac	30	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	30	30
Fenofibrate	Fenofibrate Nanocrystallized	29	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	suppressed
Risperidone	Risperidone	28	suppressed
Acyclovir	Acyclovir	27	14
Baclofen	Baclofen	27	suppressed
Ibandronate Sodium	Ibandronate Sodium	27	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	27	23
Rexulti	Brexpiprazole	27	suppressed
Spiriva Handihaler	Tiotropium Bromide	27	suppressed
Sucralfate	Sucralfate	27	11
Amiodarone Hcl	Amiodarone Hcl	26	suppressed
Clindamycin Hcl	Clindamycin Hcl	26	23
Creon	Lipase/Protease/Amylase	26	suppressed
Lovastatin	Lovastatin	25	suppressed
Megestrol Acetate	Megestrol Acetate	25	suppressed
Primidone	Primidone	25	suppressed
Raloxifene Hcl	Raloxifene Hcl	25	suppressed
Ranolazine Er	Ranolazine	25	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	25	suppressed
Brilinta	Ticagrelor	24	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	24	suppressed
Clotrimazole	Clotrimazole	24	17
Chlorthalidone	Chlorthalidone	23	11
Dutasteride	Dutasteride	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Seroquel	Quetiapine Fumarate	22	suppressed
Tresiba Flextouch U-100	Insulin Degludec	22	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	21	suppressed
Tobramycin	Tobramycin	21	16
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Prazosin Hcl	Prazosin Hcl	20	suppressed
Wegovy	Semaglutide	20	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	19	suppressed
Tresiba Flextouch U-200	Insulin Degludec	19	suppressed
Trileptal	Oxcarbazepine	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Ibu	Ibuprofen	18	suppressed
Roflumilast	Roflumilast	18	suppressed
Tradjenta	Linagliptin	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Lexapro	Escitalopram Oxalate	17	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Indomethacin	Indomethacin	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Clarithromycin	Clarithromycin	15	13
Nitrofurantoin	Nitrofurantoin Macrocrystal	15	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	15	suppressed
Penicillin V Potassium	Penicillin V Potassium	15	13
Repatha Sureclick	Evolocumab	15	suppressed
Temazepam	Temazepam	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Colchicine	Colchicine	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Droplet Insulin Syringe	Syringe And Needle,insulin,1ml	14	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	14	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Methimazole	Methimazole	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Metronidazole	Metronidazole	14	13
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Xolair	Omalizumab	14	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	13	13
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Risperdal	Risperidone	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Ubrelvy	Ubrogepant	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Chlorzoxazone	Chlorzoxazone	11	suppressed
Cholestyramine Light	Cholestyramine	11	suppressed
Dapsone	Dapsone	11	suppressed
Dexamethasone	Dexamethasone	11	suppressed
Divalproex Sodium Er	Divalproex Sodium	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lidocaine	Lidocaine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$88.23 · 5 records	Vanda Pharmaceuticals Inc.	FANAPT, Ozempic, Rybelsus	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Ozempic play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error